Respiratory Medicine
Volume 96 , Pages S31-S35 , April 2002

Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants

  • J. YOUNG

      Affiliations

    • Research and Development, MedImmune Inc. Gaithersburg, MD, U.S.A.

References 

    REFERENCES
  1. Cowan NJ, Milstein C. Automatic monitoring of biochemical parameters in tissue culture. Studies on synchronously growing mouse myeloma cells. Biochem J. 1972;128:445–454
  2. Beeler JA, van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol. 1989;63:2941–2950
  3. Johnson S, Oliver C, Prince GA. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis. 1997;176:1215–1224

PII: S0954-6111(02)91298-9

doi: 10.1053/rmed.2002.1298

Respiratory Medicine
Volume 96 , Pages S31-S35 , April 2002